270 related articles for article (PubMed ID: 38473357)
1. Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma.
Halle-Smith JM; Pearce H; Nicol S; Hall LA; Powell-Brett SF; Beggs AD; Iqbal T; Moss P; Roberts KJ
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473357
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Microbiome in Pancreatic Cancer.
Miyabayashi K; Ijichi H; Fujishiro M
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139638
[TBL] [Abstract][Full Text] [Related]
4. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.
Gautam SK; Batra SK; Jain M
Mol Cancer; 2023 Jul; 22(1):118. PubMed ID: 37488598
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.
Merali N; Chouari T; Kayani K; Rayner CJ; Jiménez JI; Krell J; Giovannetti E; Bagwan I; Relph K; Rockall TA; Dhillon T; Pandha H; Annels NE; Frampton AE
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205769
[TBL] [Abstract][Full Text] [Related]
6. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.
Bandi DSR; Sarvesh S; Farran B; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2023; 71-72():26-39. PubMed ID: 37407355
[TBL] [Abstract][Full Text] [Related]
7. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.
Abdul Rahman R; Lamarca A; Hubner RA; Valle JW; McNamara MG
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359684
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and pancreatic cancer cachexia: An evolving relationship.
Hendifar A; Akinsola R; Muranaka H; Osipov A; Thomassian S; Moshayedi N; Yang J; Jacobs J; Devkota S; Bhowmick N; Gong J
World J Gastrointest Oncol; 2022 Jul; 14(7):1218-1226. PubMed ID: 36051103
[TBL] [Abstract][Full Text] [Related]
9. B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients.
Vietsch EE; Latifi D; Verheij M; van der Oost EWA; de Wilde RF; Haen R; van den Boom AL; Koerkamp BG; Doornebosch PG; van Verschuer VMT; Ooms AHAG; Mohammad F; Willemsen M; Aerts JGJV; Krog RT; de Miranda NFCC; van den Bosch TPP; Mueller YM; Katsikis PD; van Eijck CHJ
Front Immunol; 2023; 14():1230306. PubMed ID: 38022530
[TBL] [Abstract][Full Text] [Related]
10. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
Huang X; Li M; Hou S; Tian B
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738624
[TBL] [Abstract][Full Text] [Related]
11. Role of microbiota and microbiota-derived short-chain fatty acids in PDAC.
Temel HY; Kaymak Ö; Kaplan S; Bahcivanci B; Gkoutos GV; Acharjee A
Cancer Med; 2023 Mar; 12(5):5661-5675. PubMed ID: 36205023
[TBL] [Abstract][Full Text] [Related]
12. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
[TBL] [Abstract][Full Text] [Related]
14. The Microbiome in PDAC-Vantage Point for Future Therapies?
Pfisterer N; Lingens C; Heuer C; Dang L; Neesse A; Ammer-Herrmenau C
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497456
[TBL] [Abstract][Full Text] [Related]
15. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective.
Panebianco C; Ciardiello D; Villani A; Maiorano BA; Latiano TP; Maiello E; Perri F; Pazienza V
Semin Cancer Biol; 2022 Nov; 86(Pt 3):997-1007. PubMed ID: 34838957
[TBL] [Abstract][Full Text] [Related]
16. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics.
Qian J; Zhang X; Wei B; Tang Z; Zhang B
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188943. PubMed ID: 37355177
[TBL] [Abstract][Full Text] [Related]
17. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.
Basu M; Philipp LM; Baines JF; Sebens S
Front Oncol; 2021; 11():740606. PubMed ID: 34631577
[TBL] [Abstract][Full Text] [Related]
18. Microbiome and MicroRNA or Long Non-Coding RNA-Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma.
Izdebska WM; Daniluk J; Niklinski J
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685710
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: A systematic review and Meta-analysis.
Hong J; Fu Y; Chen X; Zhang Y; Li X; Li T; Liu Y; Fan M; Lin R
Int J Surg; 2024 Jun; ():. PubMed ID: 38847785
[TBL] [Abstract][Full Text] [Related]
20. The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data.
Yu D; Wang T; Liang D; Mei Y; Zou W; Guo S
Front Oncol; 2021; 11():651350. PubMed ID: 34136388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
